Ryoko Araki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ryoko Araki has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Masumi Abe
Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan
11 shared publications - Hayao Nakanishi
Laboratory of Pathology and Clinical Research, Aichi Cancer Center Aichi Hospital, Okazaki 444-0011, Japan
6 shared publications - Hiroyuki Maki
Department of Radiology, Fujita Health University School of Medicine, Toyoake
6 shared publications Kiyotaka Kuzushima
6 shared publicationsMinako Tatsumi
6 shared publicationsMiwa Haruta
6 shared publications
Latest Publications
- Open Access
- 11 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
iPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms
Genomic aberrations are a critical impediment for the safe medical use of iPSCs and their origin and developmental mechanisms remain unknown. Here we find through WGS analysis of human and mouse iPSC lines that genomic mutations are de novo events and that, in addition to unmodified cytosine base prone to deamination, the DNA methylation sequence CpG represents a significant mutation-prone site. CGI and TSS regions show increased mutations in iPSCs and elevated mutations are observed in retrotransposons, especially in the AluY subfamily. Furthermore, increased cytosine to thymine mutations are observed in differentially methylated regions. These results indicate that in addition to deamination of cytosine, demethylation of methylated cytosine, which plays a central role in genome reprogramming, may act mutagenically during iPSC generation.
- 11 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessiPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms
Genomic aberrations are a critical impediment for the safe medical use of iPSCs and their origin and developmental mechanisms remain unknown. Here we find through WGS analysis of human and mouse iPSC lines that genomic mutations are de novo events and that, in addition to unmodified cytosine base prone to deamination, the DNA methylation sequence CpG represents a significant mutation-prone site. CGI and TSS regions show increased mutations in iPSCs and elevated mutations are observed in retrotransposons, especially in the AluY subfamily. Furthermore, increased cytosine to thymine mutations are observed in differentially methylated regions. These results indicate that in addition to deamination of cytosine, demethylation of methylated cytosine, which plays a central role in genome reprogramming, may act mutagenically during iPSC generation.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods from Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells
Supplementary Materials and Methods
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods from Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells
Supplementary Materials and Methods
- Open Access
- 23 September 2021
- Published by Elsevier in Stem Cell Reports
- Vol. 16 (10) , 2503-2519
Insertion/deletion and microsatellite alteration profiles in induced pluripotent stem cells
- 23 September 2021
- Published by Elsevier in Stem Cell Reports
- Vol. 16 (10) , 2503-2519
Open AccessInsertion/deletion and microsatellite alteration profiles in induced pluripotent stem cells
- Open Access
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabg5554
Evaluating the long-term effect of space radiation on the reproductive normality of mammalian sperm preserved on the International Space Station
The effect of space radiation on offspring was evaluated using mouse freeze-dried spermatozoa preserved on the Space Station.
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabg5554
Open AccessEvaluating the long-term effect of space radiation on the reproductive normality of mammalian sperm preserved on the International Space Station
The effect of space radiation on offspring was evaluated using mouse freeze-dried spermatozoa preserved on the Space Station.
- Open Access
- 10 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-17
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
A number of point mutations have been identified in reprogrammed pluripotent stem cells such as iPSCs and ntESCs. The molecular basis for these mutations has remained elusive however, which is a considerable impediment to their potential medical application. Here we report a specific stage at which iPSC generation is not reduced in response to ionizing radiation, i.e. radio-resistance. Quite intriguingly, a G1/S cell cycle checkpoint deficiency occurs in a transient fashion at the initial stage of the genome reprogramming process. These cancer-like phenomena, i.e. a cell cycle checkpoint deficiency resulting in the accumulation of point mutations, suggest a common developmental pathway between iPSC generation and tumorigenesis. This notion is supported by the identification of specific cancer mutational signatures in these cells. We describe efficient generation of human integration-free iPSCs using erythroblast cells, which have only a small number of point mutations and INDELs, none of which are in coding regions.
- 10 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-17
Open AccessGenetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
A number of point mutations have been identified in reprogrammed pluripotent stem cells such as iPSCs and ntESCs. The molecular basis for these mutations has remained elusive however, which is a considerable impediment to their potential medical application. Here we report a specific stage at which iPSC generation is not reduced in response to ionizing radiation, i.e. radio-resistance. Quite intriguingly, a G1/S cell cycle checkpoint deficiency occurs in a transient fashion at the initial stage of the genome reprogramming process. These cancer-like phenomena, i.e. a cell cycle checkpoint deficiency resulting in the accumulation of point mutations, suggest a common developmental pathway between iPSC generation and tumorigenesis. This notion is supported by the identification of specific cancer mutational signatures in these cells. We describe efficient generation of human integration-free iPSCs using erythroblast cells, which have only a small number of point mutations and INDELs, none of which are in coding regions.